Title:
グルココルチコイドおよびβ2-アドレナリン受容体アゴニストを含む吸入用製剤
Document Type and Number:
Japanese Patent JP2005523268
Kind Code:
A
Abstract:
According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula I, wherein R1 represents C1-6 alkyl or C1-6 haloalkyl R2 represents -C=O-aryl or -C=O-heteroaryl R3 represents hydrogen, methyl which may be in either the alpha or beta configuration or methylene R4 and R5 are the same or different and each represents hydrogen or halogen and a represents a single or a double bond and salts and solvates thereof together with a long-acting beta2-adrenoreceptor agonist which formulation has a therapeutically useful effect in the treatment of inflammatory disorders of the respiratory tract over a period of 24 hours or more.
Inventors:
Bigger dyke, keith
Jones, Paul
Payne, Jeremy, John
Jones, Paul
Payne, Jeremy, John
Application Number:
JP2003565457A
Publication Date:
August 04, 2005
Filing Date:
February 04, 2003
Export Citation:
Assignee:
GLAXO GROUP LIMITED
International Classes:
A61K9/72; A61K9/00; A61K31/135; A61K31/18; A61K31/568; A61K31/573; A61K31/58; A61K45/00; A61K45/06; A61K47/26; A61P11/06; A61P29/00; A61P37/08; (IPC1-7): A61K31/568; A61K9/72; A61K31/135; A61K45/00; A61K47/26; A61P11/06; A61P29/00; A61P37/08
Attorney, Agent or Firm:
Yusuke Hiraki
Ishii Teiji
Satoshi Fujita
Ishii Teiji
Satoshi Fujita